mFAST-SeqS based aneuploidy score in circulating cell-free DNA and role as early response marker in patients with metastatic prostate cancer treated with androgen receptor signaling inhibitor.

Authors

null

Khrystany T. Isebia

Erasmus MC Cancer Institute, Rotterdam, Netherlands

Khrystany T. Isebia , Anouk de Jong , Vanja de Weerd , Corine Beaufort , Paul Hamberg , Martijn P. Lolkema , Saskia M Wilting , Ronald De Wit , John W.M. Martens , Maurice P. H. M. Jansen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT01855477, NTR5732

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5058)

DOI

10.1200/JCO.2023.41.16_suppl.5058

Abstract #

5058

Poster Bd #

152

Abstract Disclosures

Similar Posters

First Author: Evan Y. Yu

First Author: Aishwarya Subramanian